Exact Mass: 375.1682
Exact Mass Matches: 375.1682
Found 241 metabolites which its exact mass value is equals to given mass value 375.1682
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Gatifloxacin
Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces an eye-drop formulation called Zymar. Gatifloxacin is available as tablets and in various aqueous solutions for intravenous therapy. [Wikipedia] J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D004791 - Enzyme Inhibitors
2-Propenamide, N-methyl-N-((3-methyl-2-benzofuranyl)methyl)-3-(5,6,7,8-tetrahydro-7-oxo-1,8-naphthyridin-3-yl)-, (2E)-
Afn-1252
Seneciphyllinine
Acetylseneciphylline is a pyrrolizine alkaloid that is seneciphylline in which the hydroxy hydrogen has been replaced by an acetyl group. It has a role as a Jacobaea metabolite. It is a macrocyclic lactone, an olefinic compound, an organic heterotricyclic compound, a pyrrolizine alkaloid and an acetate ester. It is functionally related to a seneciphylline. CID 15120074 is a natural product found in Senecio rodriguezii and Senecio pterophorus with data available. A pyrrolizine alkaloid that is seneciphylline in which the hydroxy hydrogen has been replaced by an acetyl group.
(13bS)-4-acetyl-8,13,13b,14-tetrahydro-1-(1-hydroxyethyl)indolo[2,3:3,4]pyrido[1,2-b] [2,7]naphthyridin-5(7H)-one|Latifoliamide E
10,16-dioxo-16,19-seco-strychnidine-19-carbonitrile|N-Cyano-sec-pseudostrychnin|N-Cyano-sec-pseudostrychnine
Gatifloxacin
A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions D004791 - Enzyme Inhibitors
Ala Ala Asn Thr
Ala Ala Gln Ser
Ala Ala Ser Gln
Ala Ala Thr Asn
Ala Gly Gln Thr
Ala Gly Thr Gln
Ala Asn Ala Thr
Ala Asn Thr Ala
Ala Gln Ala Ser
Ala Gln Gly Thr
Ala Gln Ser Ala
Ala Gln Thr Gly
Ala Ser Ala Gln
Ala Ser Gln Ala
Ala Thr Ala Asn
Ala Thr Gly Gln
Ala Thr Asn Ala
Ala Thr Gln Gly
Asp Gly Gly Lys
Asp Gly Lys Gly
Asp Lys Gly Gly
Gly Ala Gln Thr
Gly Ala Thr Gln
Gly Asp Gly Lys
Gly Asp Lys Gly
Gly Gly Asp Lys
Gly Lys Asp Gly
Gly Asn Ser Val
Gly Asn Val Ser
Gly Gln Ala Thr
Gly Gln Thr Ala
Gly Ser Asn Val
Gly Ser Val Asn
Gly Thr Ala Gln
Gly Thr Gln Ala
Gly Val Asn Ser
Gly Val Ser Asn
Lys Asp Gly Gly
Lys Gly Asp Gly
Asn Ala Ala Thr
Asn Ala Thr Ala
Asn Gly Ser Val
Asn Gly Val Ser
Asn Ser Gly Val
Asn Ser Val Gly
Asn Thr Ala Ala
Asn Val Gly Ser
Asn Val Ser Gly
Gln Ala Ala Ser
Gln Ala Gly Thr
Gln Ala Ser Ala
Gln Ala Thr Gly
Gln Gly Ala Thr
Gln Gly Thr Ala
Gln Ser Ala Ala
Gln Thr Ala Gly
Gln Thr Gly Ala
Ser Ala Ala Gln
Ser Ala Gln Ala
Ser Gly Asn Val
Ser Gly Val Asn
Ser Asn Gly Val
Ser Asn Val Gly
Ser Gln Ala Ala
Ser Val Gly Asn
Ser Val Asn Gly
Thr Ala Ala Asn
Thr Ala Gly Gln
Thr Ala Asn Ala
Thr Ala Gln Gly
Thr Gly Ala Gln
Thr Gly Gln Ala
Thr Asn Ala Ala
Thr Gln Ala Gly
Thr Gln Gly Ala
Val Gly Asn Ser
Val Gly Ser Asn
Val Asn Gly Ser
Val Asn Ser Gly
Val Ser Gly Asn
Val Ser Asn Gly
Urea, N-[(2-chloro-6-ethoxy-3-quinolinyl)methyl]-N-cyclopentyl-N,N-dimethyl- (9CI)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(4-methoxyphenyl)- (9CI)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(3-methoxyphenyl)- (9CI)
Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-(2-methoxyphenyl)- (9CI)
Urea, N-[2-[(3-cyano-6-methyl-2-quinolinyl)amino]ethyl]-N-(4-methoxyphenyl)- (9CI)
Urea, N-[2-[(3-cyano-6-methyl-2-quinolinyl)amino]ethyl]-N-(3-methoxyphenyl)- (9CI)
Urea, N-[2-[(3-cyano-6-methyl-2-quinolinyl)amino]ethyl]-N-(2-methoxyphenyl)- (9CI)
METHYL 9-[METHYL-4-(TRIFLUOROMETHOXY)ANILINO]-9-OXONONANOATE
Nalmefene hydrochloride
D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist
Ciprofloxacin-D8 hydrochloride hydrate (see Data Sheet)
2,2-IMinobis(N-(2,6-Dimethylphenyl)acetiamide Hydrochloride
Pipethanate hydrochloride
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
1-(2-(4-Azidophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine
1-cyclopropyl-6-fluoro-8-methoxy-7-[(3S)-3-methylpiperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Glu-Asp-Ile
A tripeptide composed of L-glutamic acid, L-aspartic acid and L-isoleucine joined in sequence by peptide linkages.